van der Kuy, P H <br/><br/>
Bioavailability of intranasal formulations of dihydroergotamine.  [electronic resource] 

 -  European journal of clinical pharmacology  Nov 1999 
 - 677-80 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>0031-6970 
<br/><br/><label>Standard No.: </label>10.1007/s002280050692  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Absorption<br/>Administration, Intranasal<br/>Adult<br/>Aerosols<br/>Area Under Curve<br/>Biological Availability<br/>Chemistry, Pharmaceutical<br/>Cross-Over Studies<br/>Cyclodextrins--administration & dosage<br/>Dihydroergotamine--administration & dosage<br/>Drug Combinations<br/>Female<br/>Humans<br/>Male<br/>Middle Aged<br/>Powders<br/>Reference Values<br/>Therapeutic Equivalency<br/>Vasoconstrictor Agents--administration & dosage<br/>beta-Cyclodextrins